Vascular Discovery 2026 Scientific Sessions  /  13. Concurrent Session 4a: Lipid Metabolism and Novel Therapeutic Targets in Atherosclerosis  /  Fueling Continual Efferocytosis: Metabolic Mechanisms and Therapeutic Potential
Logo

American Heart Association

  18
  0

Final ID:

Fueling Continual Efferocytosis: Metabolic Mechanisms and Therapeutic Potential

  • Yurdagul, Arif  ( LSUHSC SHREVEPORT , Shreveport , Louisiana , United States )
    • Author Disclosures:
    Arif Yurdagul: DO NOT have relevant financial relationships
Meeting Info:

Vascular Discovery 2026 Scientific Sessions

2026

Bellevue, Washington

Session Info:

13. Concurrent Session 4a: Lipid Metabolism and Novel Therapeutic Targets in Atherosclerosis

Friday, 05/15/2026 , 03:30PM - 05:00PM

Oral

More abstracts on this topic:
Lipoproteins are susceptible to proteolytic modifications that may alter their atherogenicity

Voy Clairity, Daugherty Alan, Gordon Scott, Karakashian Alexander, Neupane Khaga, Howatt Deborah, Hage Olivia, Barney Ryan, Merritt-dorosin Archer, Helsley Robert, Lu Hong

Rethinking Lp(a) Metabolism: Do Extracellular Vesicles Shape Its Fate?

Reyes-soffer Gissette

More abstracts from these authors:
EHD1 enhances macrophage inflammation to exacerbate the progression of atherosclerosis

Ma Fanglin, Cai Bishuang, Xu Yang, Liu Yu, Gupta Neha, Liu Wenli, Huang Xin, Fidler Trevor, Yurdagul Arif, Orr Wayne

The atherosclerosis landscape

Yurdagul Arif

You have to be authorized to contact abstract author. Please, Login
Not Available